Your browser doesn't support javascript.
loading
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach.
Greenhawt, Matthew; Dribin, Timothy E; Abrams, Elissa M; Shaker, Marcus; Chu, Derek K; Golden, David B K; Akin, Cem; Anagnostou, Akterini; ALMuhizi, Faisal; Alqurashi, Waleed; Arkwright, Peter; Baldwin, James L; Banerji, Aleena; Bégin, Philippe; Ben-Shoshan, Moshe; Bernstein, Jonathan; Bingemann, Theresa A; Bindslev-Jensen, Carsten; Blumenthal, Kim; Byrne, Aideen; Cahill, Julia; Cameron, Scott; Campbell, Dianne; Campbell, Ronna; Cavender, Michael; Chan, Edmond S; Chinthrajah, Sharon; Comberiati, Pasquale; Eastman, Jacqueline J; Ellis, Anne K; Fleischer, David M; Fox, Adam; Frischmeyer-Guerrerio, Pamela A; Gagnon, Remi; Garvey, Lene H; Grayson, Mitchell H; Isabwe, Ghislaine Annie Clarisse; Hartog, Nicholas; Hendron, David; Horner, Caroline C; Hourihane, Johnathan O'B; Iglesia, Edward; Kan, Manstein; Kaplan, Blanka; Katelaris, Constance H; Kim, Harold; Kelso, John M; Khan, David A; Lang, David; Ledford, Dennis.
Afiliação
  • Greenhawt M; Section of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo. Electronic address: Matthew.Greenhawt@childrenscolorado.org.
  • Dribin TE; Division of Emergency Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio.
  • Abrams EM; Department of Pediatrics and Child Health, Section of Allergy and Immunology, The University of Manitoba, Winnipeg, Canada.
  • Shaker M; Dartmouth-Hitchcock Medical Center, Section of Allergy and Immunology, Lebanon, NH; Dartmouth Geisel School of Medicine, Hanover, NH.
  • Chu DK; Faculty of Medicine, and the Department of McMaster University, Hamilton, Canada; Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada; The Research Institute of St. Joe's Hamilton, Hamilton, Canada; Evidence in Allergy Group, McMaster University Medical
  • Golden DBK; Division of Allergy and Clinical Immunology, Johns Hopkins University School of Medicine, Baltimore, Bethesda.
  • Akin C; Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Michigan School, Ann Arbor, Mich.
  • Anagnostou A; Section of Immunology, Allergy, and Retrovirology, Department of Pediatrics, Baylor College of Medicine, Houston, Tex; Section of Immunology, Allergy and Retrovirology, Department of Pediatrics, Texas Children's Hospital, Houston, Tex.
  • ALMuhizi F; Division of Allergy and Clinical Immunology, Department of Internal Medicine, Security Forces Hospital Program, Riyadh, Arabia.
  • Alqurashi W; Department of Pediatrics and Emergency Medicine, University of Ottawa, Ottawa, Canada.
  • Arkwright P; Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom.
  • Baldwin JL; Division of Allergy and Clinical Immunology, Department of Internal Medicine, University of Michigan School, Ann Arbor, Mich.
  • Banerji A; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
  • Bégin P; Centre Hospital Universitaire Sainte-Justine, Montreal, Canada.
  • Ben-Shoshan M; Division of Allergy, Immunology, and Dermatology, Department of Pediatrics, McGill University Health Center-Montreal Children's Hospital, Montreal, Canada.
  • Bernstein J; Division of Immunology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio.
  • Bingemann TA; Division of Allergy, Immunology, and Rheumatology, University of Rochester School of Medicine and Dentistry, Rochester, NY.
  • Bindslev-Jensen C; Department of Dermatology and Allergy Center, Odense Research Centre for Anaphylaxis, Odense, Denmark.
  • Blumenthal K; Division of Rheumatology, Allergy, and Immunology, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Mass.
  • Byrne A; Department of Paediatrics, School of Medicine, Trinity College Dublin, Dublin, Ireland.
  • Cahill J; University of Alberta, Faculty of Medicine, Calgary, Canada.
  • Cameron S; Allergy Victoria, Victoria, British Columbia, Canada.
  • Campbell D; The Children's Hospital at Westmead, Sydney, Australia.
  • Campbell R; Department of Emergency Medicine, Mayo Clinic, Rochester.
  • Cavender M; Carilion Clinic, Verona, Va.
  • Chan ES; Division of Allergy and Immunology, BC Children's Hospital, The University of British Columbia, Vancouver, Canada.
  • Chinthrajah S; Division of Pulmonary, Allergy and Critical Care, Department of Medicine, Stanford University School of Medicine, Palo Alto, Calif; Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, Calif; Sean N. Parker Center for Allergy
  • Comberiati P; Department of Clinical and Experimental Medicine, Section of Pediatrics, University of Pisa, Pisa, Italy.
  • Eastman JJ; Corewell Health Allergy and Immunology, Grand Rapids, Mich; Michigan State University College of Human Medicine, Grand Rapids, Mich.
  • Ellis AK; Division of Allergy and Immunology, Department of Medicine, Queen's University, Kingston, Canada.
  • Fleischer DM; Section of Allergy and Clinical Immunology, Children's Hospital Colorado, University of Colorado School of Medicine, Aurora, Colo.
  • Fox A; Guys's and St Tomas's Hospital National Health Service Foundation Trust, London, Mass.
  • Frischmeyer-Guerrerio PA; Laboratory of Allergic Diseases, Food Allergy Research Section, National Institutes of Allergy and Infectious Diseases, the National Institutes of Health, Bethesda, Md.
  • Gagnon R; Clinique Spécialisée en Allergie de la Capitale, Québec, Canada.
  • Garvey LH; Allergy Clinic, Department of Dermatology and Allergy, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
  • Grayson MH; Division of Allergy and Immunology, Department of Pediatrics, Nationwide Children's Hospital, The Ohio State University College of Medicine, Columbus, Ohio.
  • Isabwe GAC; Division of Allergy, Immunology, and Dermatology, Department of Pediatrics, McGill University Health Center-Montreal Children's Hospital, Montreal, Canada.
  • Hartog N; Corewell Health Allergy and Immunology, Grand Rapids, Mich; Michigan State University College of Human Medicine, Grand Rapids, Mich.
  • Hendron D; Access Health Care Physicians LLC, New Port Richey, Fla.
  • Horner CC; Division of Allergy and Pulmonary Medicine, Department of Pediatrics, Washington University School of Medicine, St Louis, Mo.
  • Hourihane JO; Department of Paediatrics, Royal College of Surgeons, Dublin, Ireland.
  • Iglesia E; Division of Allergy, Pulmonary and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn.
  • Kan M; Fraser Allergy, Langley, Canada.
  • Kaplan B; Division of Allergy and Immunology, Northwell Health, New York, NY.
  • Katelaris CH; Campbelltown Hospital, Western Sydney University, Sydney, Australia.
  • Kim H; Faculty of Medicine, and the Department of McMaster University, Hamilton, Canada; Division of Clinical Immunology and Allergy, Department of Medicine, Western University, St Joseph's Health Care, London (Canada), Mass.
  • Kelso JM; Division of Allergy, Asthma, and Immunology, Scripps Clinic, San Diego, Calif.
  • Khan DA; Division of Allergy and Immunology, Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Tex.
  • Lang D; Department of Allergy and Clinical Immunology, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio.
  • Ledford D; Division of Allergy and Immunology, Department of Medicine, University of South Florida Morsani College of Medicine, Tampa, Fla.
J Allergy Clin Immunol ; 152(2): 309-325, 2023 08.
Article em En | MEDLINE | ID: mdl-37295474
ABSTRACT
This guidance updates 2021 GRADE (Grading of Recommendations Assessment, Development and Evaluation) recommendations regarding immediate allergic reactions following coronavirus disease 2019 (COVID-19) vaccines and addresses revaccinating individuals with first-dose allergic reactions and allergy testing to determine revaccination outcomes. Recent meta-analyses assessed the incidence of severe allergic reactions to initial COVID-19 vaccination, risk of mRNA-COVID-19 revaccination after an initial reaction, and diagnostic accuracy of COVID-19 vaccine and vaccine excipient testing in predicting reactions. GRADE methods informed rating the certainty of evidence and strength of recommendations. A modified Delphi panel consisting of experts in allergy, anaphylaxis, vaccinology, infectious diseases, emergency medicine, and primary care from Australia, Canada, Europe, Japan, South Africa, the United Kingdom, and the United States formed the recommendations. We recommend vaccination for persons without COVID-19 vaccine excipient allergy and revaccination after a prior immediate allergic reaction. We suggest against >15-minute postvaccination observation. We recommend against mRNA vaccine or excipient skin testing to predict outcomes. We suggest revaccination of persons with an immediate allergic reaction to the mRNA vaccine or excipients be performed by a person with vaccine allergy expertise in a properly equipped setting. We suggest against premedication, split-dosing, or special precautions because of a comorbid allergic history.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Hipersensibilidade Imediata / Anafilaxia Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 / Hipersensibilidade Imediata / Anafilaxia Tipo de estudo: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2023 Tipo de documento: Article